3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
2
Gynecologic
2
Gastrointestinal
2
Sarcoma
1
Conditions
Stomach Neoplasms
34
Ovarian Neoplasms
29
Peritoneal Neoplasms
27
Fallopian Tube Neoplasms
14
Colorectal Neoplasms
14
Carcinoma, Ovarian Epithelial
11
Appendiceal Neoplasms
7
Neoplasm Metastasis
4
Uterine Neoplasms
3
Recurrence
3
Pseudomyxoma Peritonei
3
Pancreatic Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Peritoneal Diseases
2
Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrointestinal Neoplasms
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Wilms Tumor
1
Stomach Diseases
1
Stage â…¢ Gastric Cancer
1
Stage IV Gastric Cancer With Metastasis
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Interventions
Cisplatin
28
Pemetrexed
24
pembrolizumab
12
Nivolumab
10
Carboplatin
9
atezolizumab
7
Gemcitabine
7
Cyclophosphamide
7
durvalumab
6
Drug Therapy
6
sodium thiosulfate
5
Radiotherapy, Intensity-Modulated
5
tremelimumab
4
aldesleukin
4
Radiotherapy
4
Interleukin-2
4
sargramostim
3
Vinorelbine
3
Platinum
3
Photochemotherapy
3
Ipilimumab
3
Doxorubicin
3
Dihematoporphyrin Ether
3
Chemotherapy, Adjuvant
3
Cerebral Decortication
3
vatalanib
2
regorafenib
2
niraparib
2
lenvatinib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma, Malignant
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT03210298
2019-10-08
PIPACRegis
University of Magdeburg
Unknown
1,000 enrolled